Skip to content

Iowa · Nonprofit

IOWA PRESCRIPTION DRUG CORPORATION

IOWA PRESCRIPTION DRUG CORPORATION (Iowa) receives grants from 9 organizations whose IRS filings report $790,223 to it, the largest being Iowa Primary Care Association Inc ($409,423). 3 of them have funded it in more than one year.

Revenue FY2025
$29M
Funders on record
9
Grants received
$790k
Net assets
$23M
3/9 repeat funderspeak grant-dependency 7%
01What it does

What Iowa Prescription Drug Corporation does

Mission

To serve the prescription needs of medically underserved populations through responsible collection and distribution of donated medicines.

As stated on its FY2025 Form 990.

Programs

  1. Drug donation repository - the purpose of this program is to collect unused prescription medications that accumulate in long-term care and other medical settings. The unused prescription medications are donated to safenetrx, inspected by pharmacists, and distributed to clinics and pharmacies that care for uninsured and underinsured patients that cannot afford needed drug therapies.

    $22,279,071 spent
    99% of program spending
  2. Charitable pharmacy - the purpose of this program is to provide pharmacy services to underserved patients that cannot afford needed drug therapies. The charitable pharmacy fills prescriptions from an inventory of donated medicine received from the drug donation repository.

    $162,213 spent
    1% of program spending
  3. To operate a prescription drug program to reduce expenditures for prescription medication for iowa's uninsured and underinsured residents

The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $22,441,284.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($5.9M) Expenses 100 ($5.9M) Net assets 100 ($768k)2018 Revenue 112 ($6.5M) Expenses 110 ($6.5M) Net assets 116 ($888k)2019 Revenue 141 ($8.3M) Expenses 138 ($8.1M) Net assets 144 ($1.1M)2020 Revenue 148 ($8.7M) Expenses 148 ($8.7M) Net assets 135 ($1.0M)2021 Revenue 152 ($8.9M) Expenses 152 ($8.9M) Net assets 131 ($1.0M)2022 Revenue 358 ($21M) Expenses 188 ($11M) Net assets 1426 ($11M)2023 Revenue 552 ($32M) Expenses 428 ($25M) Net assets 2370 ($18M)2024 Revenue 378 ($22M) Expenses 400 ($23M) Net assets 2198 ($17M)2025 Revenue 495 ($29M) Expenses 386 ($23M) Net assets 3029 ($23M)
'17'18'19'20'21'22'23'24'25
Revenue (495)Expenses (386)Net assets (3029)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $1.3M to $12M (+774%).

$941k
$1.1M
$1.2M
$1.3M
$1.3M
$12M
$19M
$17M
$24M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 2% · 2018 6% · 2019 0% · 2022 9% · 2023 2% · 2024 3% · 2025 2%. Grants only. Government contracts and fees sit inside program revenue.

100% of IOWA PRESCRIPTION DRUG CORPORATION’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).

This organization
Typical peer · 4,743 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 9 reported years ran a deficit.

$2k
’17
$82k
’18
$156k
’19
−$18k
’20
$1k
’21
$10.0M
’22
$7.3M
’23
−$1.3M
’24
$6.4M
’25
0.0
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Jon Rosmann

CEO

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed111313131414121515
Joined·+3+0+1+2+5+1+3+1
No longer listed·10115301
03Who funds it

Who funds it, year by year

2017 → 2023: the base narrowed from 3 funders to 2 funders, grant income fell $429k → $131.

1 of 9 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 0% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of IOWA PRESCRIPTION DRUG CORPORATION’s funders (the co-funder graph). Top 7 of 9 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

IOWA PRESCRIPTION DRUG CORPORATION leans on a few funders — its largest provides 52% of grant income and the top three 96%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

62% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund IOWA PRESCRIPTION DRUG CORPORATION.

52%
largest funder
96%
top three
~2
effective funders

Largest funder’s share by year: 2017 95% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

56% of IOWA PRESCRIPTION DRUG CORPORATION's grant income comes from Iowa funders.

IA
NE
VA

Funder states come from each funder’s own filing. $1k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

IOWA PRESCRIPTION DRUG CORPORATION runs a healthier operating margin than three-quarters of the 2,843 health nonprofits its size.

Operating margin22% · top quartile
Months of reserve0.0mo · bottom quartile
Revenue growth (annualized)22% · top quartile

this organization peer median middle 50% of peers· 2,843 health nonprofits $10M–$100M, FY2025

Organizations like IOWA PRESCRIPTION DRUG CORPORATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Iowa

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

99% of spending goes to programs.

Program 99%Management 1%Fundraising 0%

Governance

14
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention–Board reviewed the 990✓Audited financials

Public support

100%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Screen this organization

A dated, signed PDF of the compliance screen for IOWA PRESCRIPTION DRUG CORPORATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds IOWA PRESCRIPTION DRUG CORPORATION?
IOWA PRESCRIPTION DRUG CORPORATION (Iowa) receives grants from 9 organizations whose IRS filings report $790,223 to it, the largest being Iowa Primary Care Association Inc ($409,423). 3 of them have funded it in more than one year.
How many funders does IOWA PRESCRIPTION DRUG CORPORATION have?
IRS filings report 9 organizations giving $790,223 in grants to IOWA PRESCRIPTION DRUG CORPORATION, 3 of which have funded it in more than one year.
Who is the largest funder of IOWA PRESCRIPTION DRUG CORPORATION?
Iowa Primary Care Association Inc is the largest funder on record, with $409,423 in grants. The full list of funders is on this page.
How can an organization like IOWA PRESCRIPTION DRUG CORPORATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Iowa. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Iowa Prescription Drug →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 9 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing